Elevai Labs, Inc. ELAB 深 滬
已收盤 09-20 16:00:00 美东时间
0.28
-0.026
-8.44%
華盛通- 最 高0.317
- 今 開0.3099
- 成交量 50.24万股
- 最 低 0.28
- 昨 收 0.3058
- 總市值 485.23万
- 52周最高 4.2442
- 市盈率 靜 --
- 換手率 2.90%
- 52周最低 0.2175
- 委 比 99.31%
- 總股本 1732.96万
- 歷史最高 4.2442
- 量 比 1.26
- 振 幅 12.10%
- 歷史最低 0.2175
- 每 手 1
- 風險率 0.74%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Elevai Labs files for 25M stock offering
Elevai Labs (NASDAQ:ELAB) files prospectus for offering up to 25M shares of common stock, together with Series A warrants to purchase up to 25M shares of common stock and Series B warrants to purchase...
09-07 05:25
ELEVAI Labs Inc. Presents at National Aesthetics Conference
ELEVAI Labs Inc. (ELAB) just unveiled an announcement. Elevai Labs Inc. has sta...
09-04 20:28
ELEVAI Labs Shares Future Direction and Financial Outlook
ELEVAI Labs Inc. (ELAB) has shared an announcement. Elevai Labs Inc. has initia...
07-16 21:28
INmune and Elevai Labs amend licensing deal
Skincare product maker Elevai Labs (NASDAQ:ELAB) announced Friday that the company and cancer drug developer INmune Bio (NASDAQ:INMB) amended a licensing deal reached early this year. According to a r...
07-12 19:12
ELEVAI Labs Announces CEO Transition and Executive Restructuring
ELEVAI Labs Inc. (ELAB) has issued an update. Dr. Jordan Plews has announced hi...
06-27 04:29
IPO roundup: KDLY, BOW, and more
Headlines making waves in the IPO sector include the recent cancellation of Games Global's (GGL) debut on public markets. The company, a casino game supplier for platforms like DraftKings (DKNG) and F...
05-20 23:11
ELEVAI Labs Expands Portfolio and Restructures Subsidiaries
The latest update is out from ELEVAI Labs Inc. (ELAB). Elevai Labs, Inc. has se...
05-03 05:42
Elevai Labs reports Q4 results
Elevai Labs press release (NASDAQ:ELAB): Q4 total comprehensive loss was $708,508 Revenue increased to $698,591 for the three months ended December 31, 2023, compared to $138,898 for the three months ...
03-30 00:51
Why Elevai Labs Stock Is Trading Higher
Elevai Labs, Inc. (NASDAQ:ELAB) shares are trading higher Tuesday after the company announced it signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune Bio, Inc. (NASDAQ:INMB).
01-17 01:41
Dow Dips 200 Points; Goldman Sachs Earnings Top Views
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.56% to 37,384.20 while the NASDAQ fell 0.69% to 14,869.02. The S&P 500 also fell, dropping, 0.53% to 4,758.60.
01-16 22:49
